propionaldehyde oxime
|
- $53 - $498
- Product name: propionaldehyde oxime
- CAS: 627-39-4
- MF: C3H7NO
- MW: 73.09
- EINECS:
- MDL Number:
- Synonyms:Propanal oxime;propionaldehyde oxime;propionaldoxime;Propanaldoxime;Propionaldehyde oxime >=96%, >=96.0% (mixture of isomers);Propanal, oxime (9CI);n-Propylidenehydroxylamine
3 prices
Selected condition：
Brand
- Adipogen Life Sciences
- AK Scientific
- American Custom Chemicals Corporation
Package
- 5MG
- 500mg
- 1g
- ManufacturerAdipogen Life Sciences
- Product numberCDX-P0059-M500
- Product descriptionPropionaldehyde oxime ≥96%(HPLC)
- Packaging500mg
- Price$53
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number0148AQ
- Product descriptionPropionaldehyde oxime
- Packaging1g
- Price$167
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0312126
- Product descriptionPROPANAL OXIME 95.00%
- Packaging5MG
- Price$498
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Adipogen Life Sciences | CDX-P0059-M500 | Propionaldehyde oxime ≥96%(HPLC) | 500mg | $53 | 2021-12-16 | Buy |
| AK Scientific | 0148AQ | Propionaldehyde oxime | 1g | $167 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0312126 | PROPANAL OXIME 95.00% | 5MG | $498 | 2021-12-16 | Buy |
Properties
Melting point :40°C
Boiling point :128.95°C (rough estimate)
Density :0.9258
refractive index :1.4287
storage temp. :2-8°C
pka :11.42±0.11(Predicted)
BRN :1098365
Boiling point :128.95°C (rough estimate)
Density :0.9258
refractive index :1.4287
storage temp. :2-8°C
pka :11.42±0.11(Predicted)
BRN :1098365
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|